Skip to main content

Gensight Biologics SA (SIGHT.PA) Stock Price and Company Information, 2024

Gensight Biologics SA

SIGHT.PA

Exchange: PA
Currency Euro
ISIN: FR0013183985
Primary Ticker: SIGHT.PA
Fiscal Year End: December
International Domestic: International/Domestic
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Biotechnology
Gic Sub Industry: Biotechnology
Description: Gen Sight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative retinal diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. It has license agreements with Sorbonne Université, CNRS, Inserm and SATT Lutech; Inserm Transfert S.A, Genethon, and Harvard; Massachusetts Institute of Technology; Novartis Pharma AG; Sorbonne University, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale and Satt Lutech; Association Française contre les Myopathies, Inserm Transfert S.A; and non-exclusive license agreement with Adverum Biotechnologies. The company was incorporated in 2012 and is headquartered in Paris, France.
Address: 74, rue du Faubourg Saint-Antoine, Paris, France, 75012
Website: https://www.gensight-biologics.com
Full Time Employees: 11
Updated On: 2024-11-05

Highlights

Market Capitalization: 34108360
Market Capitalization Mln: 34.10
EBITDA: -19212000
Wall Street Target Price: 0.4
Book Value: -0.24
Earnings Share: -0.35
EPS Estimate Current Year: -0.47
EPS Estimate Next Year: -0.65
Most Recent Quarter: 2024-06-30
Operating Margin TTM: -4.28
Return On Assets TTM: -0.78
Return On Equity TTM: -77.81
Revenue TTM: 1976000
Revenue Per Share TTM: 0.03
Quarterly Revenue Growth YOY: -0.36
Gross Profit TTM: 4865000
Diluted Eps TTM: -0.35

Valuation

Price Sales TTM: 17.26
Price Book MRQ: 30.40
Enterprise Value: 44868864
Enterprise Value Revenue: 55.80
Enterprise Value Ebitda: -3.00

Technicals

Beta: 2.29
52 Week High: 0.68
52 Week Low: 0.28
50 Day MA: 0.36
200 Day MA: 0.37

Earnings

Report Date: 2025-05-29
Date: 2025-03-31
Before After Market: After Market
Currency: EUR
Report Date: 2025-03-20
Date: 2024-12-31
Before After Market: After Market
Currency: EUR
Report Date: 2024-10-24
Date: 2024-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2024-06-20
Date: 2024-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2023-10-26
Date: 2023-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2023-09-15
Date: 2023-06-30
Before After Market: After Market
Currency: EUR
Report Date: 2023-05-11
Date: 2023-03-31
Before After Market: Before Market
Currency: EUR
Report Date: 2023-03-24
Date: 2022-12-31
Before After Market: Before Market
Currency: EUR
Report Date: 2022-10-28
Date: 2022-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2022-07-28
Date: 2022-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.23
Report Date: 2022-04-21
Date: 2022-03-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.63
Eps Difference: -0.63
Report Date: 2021-11-10
Date: 2021-09-30
Before After Market: Before Market
Currency: EUR
Report Date: 2021-07-29
Date: 2021-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.19
Eps Difference: -0.19
Report Date: 2021-04-20
Date: 2021-03-31
Currency: EUR
Report Date: 2021-03-10
Date: 2020-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.53
Eps Difference: -0.53
Report Date: 2020-10-20
Date: 2020-09-30
Currency: EUR
Report Date: 2020-07-30
Date: 2020-06-30
Before After Market: After Market
Currency: EUR
Eps Actual: -0.43
Eps Difference: -0.43
Report Date: 2020-04-21
Date: 2020-03-31
Currency: EUR
Report Date: 2020-03-12
Date: 2019-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.46
Eps Difference: -0.46
Report Date: 2019-10-22
Date: 2019-09-30
Currency: EUR
Report Date: 2019-07-24
Date: 2019-06-30
Before After Market: After Market
Currency: EUR
Eps Actual: -0.63
Eps Difference: -0.63
Report Date: 2019-04-24
Date: 2019-03-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.88
Eps Difference: -0.88
Report Date: 2018-10-24
Date: 2018-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2018-07-25
Date: 2018-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.48
Eps Difference: -0.48
Report Date: 2018-05-30
Date: 2018-03-31
Currency: EUR
Report Date: 2018-02-28
Date: 2017-12-31
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.51
Eps Difference: -0.51
Report Date: 2017-07-28
Date: 2017-06-30
Before After Market: Before Market
Currency: EUR
Eps Actual: -0.51
Eps Difference: -0.51
Date: 2025-12-31
Period: +1y
Growth: -0.38
Earnings Estimate Avg: -0.65
Earnings Estimate Low: -0.80
Earnings Estimate High: -0.50
Earnings Estimate Year Ago Eps: -0.47
Earnings Estimate Number Of Analysts: 2.00
Earnings Estimate Growth: -0.38
Revenue Estimate Avg: 3500000.00
Revenue Estimate High: 7000000.00
Revenue Estimate Number Of Analysts: 2.00
Revenue Estimate Growth: 0.75
Eps Trend Current: -0.65
Eps Trend7days Ago: -0.65
Eps Trend30days Ago: -0.53
Eps Trend60days Ago: -0.53
Eps Trend90days Ago: -0.36
Date: 2024-12-31
Growth: 0.21
Earnings Estimate Avg: -0.47
Earnings Estimate Low: -0.54
Earnings Estimate High: -0.41
Earnings Estimate Year Ago Eps: -0.60
Earnings Estimate Number Of Analysts: 2.00
Earnings Estimate Growth: 0.21
Revenue Estimate Avg: 2000000.00
Revenue Estimate High: 4000000.00
Revenue Estimate Number Of Analysts: 2.00
Revenue Estimate Growth: -0.33
Eps Trend Current: -0.47
Eps Trend7days Ago: -0.47
Eps Trend30days Ago: -0.49
Eps Trend60days Ago: -0.49
Eps Trend90days Ago: -0.54
Eps Revisions Up Last30days: 1.00
Date: 2024-09-30
Period: +1q
Date: 2024-06-30
Date: 2024-03-31
Revenue Estimate Growth: -0.68
Date: 2023-12-31
Growth: 0.08
Earnings Estimate Avg: -0.55
Earnings Estimate Low: -0.65
Earnings Estimate High: -0.41
Earnings Estimate Year Ago Eps: -0.60
Earnings Estimate Number Of Analysts: 3.00
Earnings Estimate Growth: 0.08
Revenue Estimate Avg: 1530000.00
Revenue Estimate High: 2600000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: -0.68
Eps Trend Current: -0.55
Eps Trend7days Ago: -0.55
Eps Trend30days Ago: -0.55
Eps Trend60days Ago: -0.55
Eps Trend90days Ago: -0.55
Date: 2023-09-30
Period: +1q
Date: 2023-06-30
Date: 2023-03-31
Revenue Estimate Avg: 4200000.00
Revenue Estimate Low: 3000000.00
Revenue Estimate High: 5500000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: -0.45
Date: 2022-12-31
Growth: -0.20
Earnings Estimate Avg: -0.76
Earnings Estimate Low: -0.88
Earnings Estimate High: -0.68
Earnings Estimate Year Ago Eps: -0.63
Earnings Estimate Number Of Analysts: 3.00
Earnings Estimate Growth: -0.20
Revenue Estimate Avg: 4200000.00
Revenue Estimate Low: 3000000.00
Revenue Estimate High: 5500000.00
Revenue Estimate Number Of Analysts: 5.00
Revenue Estimate Growth: -0.45
Eps Trend Current: -0.76
Eps Trend7days Ago: -0.76
Eps Trend30days Ago: -0.80
Eps Trend60days Ago: -0.79
Eps Trend90days Ago: -0.79
Eps Revisions Up Last30days: 1.00
Date: 2022-09-30
Date: 2022-06-30
Date: 2019-12-31
Period: +1y
Revenue Estimate Avg: 4910000.00
Revenue Estimate High: 7000000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: -0.63
Eps Trend7days Ago: -0.90
Eps Trend30days Ago: -0.90
Eps Trend60days Ago: -0.90
Eps Trend90days Ago: -0.90
Date: 2019-06-30
Period: +1q
Revenue Estimate Avg: 13600000.00
Revenue Estimate High: 37000000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: 2.67
Date: 2019-03-31
Revenue Estimate Avg: 13600000.00
Revenue Estimate High: 37000000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: 2.67
Date: 2018-12-31
Revenue Estimate Avg: 13600000.00
Revenue Estimate High: 37000000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: 2.67
Eps Trend7days Ago: -0.57
Eps Trend30days Ago: -0.57
Eps Trend60days Ago: -0.57
Eps Trend90days Ago: -0.57
Date: 2024-09-30
Date: 2022-12-31
Eps Actual: -1.0
Date: 2020-12-31
Eps Actual: -0.9
Date: 2019-12-31
Eps Actual: -2.4
Date: 2017-12-31
Eps Actual: -1.0